VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
MNPR
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
MNPRMonopar Therapeutics Inc.
$95.22$638M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksMNPRQuarterly Financials

Monopar Therapeutics Inc. (MNPR) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Monopar Therapeutics Inc. (MNPR) quarterly income statement — complete revenue, gross profit & net income history

MNPR Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue00000000000000000000
Revenue Growth %--------------------
Cost of Goods Sold00000000000000000000
COGS % of Revenue--------------------
Gross Profit00000000000000000000
Gross Margin %--------------------
Gross Profit Growth %--------------------
Operating Expenses5.23M6.16M4.09M3.23M3.22M11.07M1.57M1.79M1.72M1.91M2.07M2.33M2.53M2.91M2.41M2.76M2.46M2.68M2.46M2.09M
OpEx % of Revenue--------------------
Selling, General & Admin1.74B2.21M1.5M1.5M1.58M1.15M590.62K657.81K757.28K876.4K749.47K733.5K871.67K806.03K675.12K684.88K779.25K698.44K631.7K615.97K
SG&A % of Revenue--------------------
Research & Development3.49M3.94M2.59M1.73M1.64M9.92M984.28K1.13M966.11K1.04M1.32M1.59M1.65M2.1M1.73M2.08M1.68M1.98M1.83M1.48M
R&D % of Revenue--------------------
Other Operating Expenses-1000K0-100000000000000000
Operating Income-5.23M-6.16M-4.09M-3.23M-3.22M-11.07M-1.57M-1.79M-1.72M-1.91M-2.07M-2.33M-2.53M-2.91M-2.41M-2.76M-2.46M-2.68M-2.46M-2.09M
Operating Margin %--------------------
Operating Income Growth %-62.18%44.42%-159.89%-80.81%-86.95%-479.22%23.77%23.17%31.75%34.27%14.18%15.75%-2.76%-8.5%2.1%-32.07%-29.69%-18.59%-49.21%-42.91%
EBITDA-5.23M-6.16M-4.09M-2.45M-3.22M-10.93M-1.3M-1.79M-1.72M0-2.07M-2.33M-2.53M0-2.41M-2.76M-2.46M00-2.09M
EBITDA Margin %--------------------
EBITDA Growth %-62.18%43.66%-213.82%-37.16%-86.95%-36.87%23.17%31.75%-14.18%15.75%-2.76%---32.07%-29.69%-100%-42.91%
D&A (Non-Cash Add-back)0000000001.91M0002.91M0002.68M2.46M0
EBIT-5.23M-6.16M-4.09M-2.45M-3.22M-10.93M-1.3M-1.79M-1.72M-1.91M-2.07M-2.33M-2.53M-2.91M-2.41M-2.76M-2.46M-2.68M-2.46M-2.09M
Net Interest Income1.33M954.43K655.47K780.77K596.85K149.04K99.34K73.47K82.17K98.07K112.26K128.22K90.49K12.66K7.7K41746452557712.23K
Interest Income1.33M954.43K655.47K780.77K596.85K149.04K99.34K73.47K82.17K98.07K112.26K128.22K90.49K12.66K7.7K41746452557712.23K
Interest Expense00000000000000000000
Other Income/Expense1.33M954.43K655.47K780.77K596.85K149.04K270.63K73.47K82.17K98.07K112.26K128.22K90.49K12.66K7.7K41746452557712.23K
Pretax Income-3.89M-5.2M-3.44M-2.45M-2.62M-10.93M-1.3M-1.72M-1.64M-1.81M-1.95M-2.2M-2.43M-2.9M-2.4M-2.76M-2.46M-2.68M-2.46M-2.08M
Pretax Margin %--------------------
Income Tax00000000000000000000
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%
Net Income-3.89M-5.2M-3.44M-2.45M-2.62M-10.93M-1.3M-1.72M-1.64M-1.81M-1.95M-2.2M-2.43M-2.9M-2.4M-2.76M-2.46M-2.68M-2.46M-2.08M
Net Margin %--------------------
Net Income Growth %-48.31%52.4%-163.56%-43.04%-59.94%-502.32%33.24%22.03%32.59%37.37%18.58%20.37%0.9%-8.05%2.39%-32.82%-30.4%-25.94%-49.96%-43.88%
Net Income (Continuing)-3.89M-5.2M-3.44M-2.45M-2.62M-10.93M-1.3M-1.72M-1.64M-1.81M-1.95M-2.2M-2.43M-2.9M-2.4M-2.76M-2.46M-2.68M-2.46M-2.08M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.46-0.78-0.48-0.35-0.38-0.95-0.11-0.15-0.10-0.12-0.14-0.16-0.19-0.22-0.19-0.22-0.19-0.21-0.20-0.17
EPS Growth %-21.05%17.89%-336.36%-133.33%-280%-691.67%21.43%6.25%47.37%45.45%26.32%27.27%0%-4.76%5%-29.41%-18.75%-10.53%-33.33%-21.43%
EPS (Basic)-0.46-0.78-0.48-0.35-0.38-0.95-0.11-0.15-0.10-0.12-0.14-0.16-0.19-0.22-0.19-0.22-0.19-0.21-0.20-0.17
Diluted Shares Outstanding8.54M6.69M7.12M7M6.99M11.48M11.48M11.48M15.98M14.9M14.12M13.42M13.11M12.95M12.76M12.63M12.6M12.58M12.58M12.57M
Basic Shares Outstanding8.54M6.69M7.12M7M6.91M11.44M11.44M11.44M15.98M14.9M14.12M13.42M13.11M12.95M12.76M12.63M12.6M12.58M12.58M12.57M
Dividend Payout Ratio--------------------